Helmut Albrecht Selected Research

Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)

7/2019

Seasonal variation in antimicrobial resistance rates of community-acquired Escherichia coli bloodstream isolates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Helmut Albrecht Research Topics

Disease

13	Infections 01/2022 - 06/2010
12	Sepsis (Septicemia) 07/2019 - 01/2015
6	COVID-19 01/2022 - 01/2020
3	Pneumonia (Pneumonitis) 01/2021 - 07/2011
2	Inflammation (Inflammations) 01/2022 - 12/2020
2	Dyslipidemias (Dyslipidemia) 01/2020 - 12/2013
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2019 - 12/2012
2	Bacteremia 01/2018 - 01/2018
2	Hypersensitivity (Allergy) 04/2016 - 10/2007
2	Acquired Immunodeficiency Syndrome (AIDS) 11/2015 - 02/2008
2	Virus Diseases (Viral Diseases) 06/2010 - 03/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Wounds and Injuries (Trauma) 01/2020
1	Chronic Hepatitis B 01/2019
1	Adenocarcinoma 01/2019
1	Cough 01/2019
1	Headache (Headaches) 01/2019
1	Heart Arrest (Cardiac Arrest) 01/2019
1	Heart Diseases (Heart Disease) 01/2019
1	Heart Failure 01/2019
1	Lymphoma (Lymphomas) 01/2019
1	Pulmonary Embolism 01/2019
1	Opportunistic Infections (Opportunistic Infection) 01/2018
1	Critical Illness (Critically Ill) 11/2017
1	Urinary Tract Infections (Urinary Tract Infection) 01/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2016
1	Diabetes Mellitus 04/2016
1	Hepatitis 02/2013
1	Obstructive Lung Diseases (Obstructive Lung Disease) 07/2011
1	Legionnaires' Disease (Legionnaire's Disease) 07/2011
1	Drug-Related Side Effects and Adverse Reactions 07/2011

Drug/Important Bio-Agent (IBA)

5	FluoroquinolonesIBA 01/2017 - 07/2011
3	Pharmaceutical PreparationsIBA 01/2022 - 02/2011
2	AntibodiesIBA 01/2022 - 06/2021
2	Immunoglobulin G (IgG)IBA 01/2022 - 06/2021
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2020
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021 - 12/2020
2	Interleukin-10 (Interleukin 10)IBA 01/2021 - 12/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 12/2020
2	Guaifenesin FDA LinkGeneric 01/2019 - 12/2012
2	dolutegravirIBA 01/2019 - 11/2013
2	Antiviral Agents (Antivirals)IBA 01/2019 - 03/2010
2	TabletsIBA 01/2019 - 01/2019
2	beta-LactamsIBA 03/2018 - 04/2016
2	LactamsIBA 01/2017 - 01/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2016 - 12/2004
1	von Willebrand FactorIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2022
1	ArginaseIBA 01/2022
1	Protein SIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	CytokinesIBA 01/2022
1	IgA receptor (protein B)IBA 01/2022
1	Histones (Histone)IBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 08/2021
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 08/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2021
1	Nucleic AcidsIBA 06/2021
1	Immunoglobulin M (IgM)IBA 06/2021
1	DNA (Deoxyribonucleic Acid)IBA 06/2021
1	Nucleocapsid ProteinsIBA 06/2021
1	oxidized low density lipoproteinIBA 01/2020
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2020
1	Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)FDA Link 07/2019
1	Cefazolin (Ancef)FDA LinkGeneric 07/2019
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 07/2019
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 07/2019
1	tenofovir alafenamideIBA 01/2019
1	Emtricitabine (Emtriva)FDA Link 01/2019
1	Tenofovir (Viread)FDA Link 01/2019
1	Expectorants (Mucolytics)IBA 01/2019
1	bictegravirIBA 01/2019
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 11/2017
1	Cefepime (Maxipime)FDA LinkGeneric 11/2017
1	NucleosidesIBA 12/2013
1	Protease Inhibitors (Protease Inhibitor)IBA 12/2013
1	Reverse Transcriptase InhibitorsIBA 12/2013
1	Raltegravir Potassium FDA Link 11/2013
1	Rilpivirine (TMC-278)IBA 02/2013
1	Ciprofloxacin (Cipro)FDA LinkGeneric 07/2011
1	Rifampin (Rifampicin)FDA LinkGeneric 07/2011
1	Erythromycin (Erycette)FDA LinkGeneric 07/2011
1	Clarithromycin (Biaxin)FDA LinkGeneric 07/2011

Therapy/Procedure

14	Therapeutics 01/2022 - 12/2004
2	Art Therapy 01/2018 - 02/2011
2	Retention in Care 01/2018 - 11/2015
1	Duration of Therapy 10/2017
1	Vascular Access Devices (Arterial Line) 05/2017
1	Length of Stay 01/2017
1	Renal Dialysis (Hemodialysis) 12/2016
1	Central Venous Catheters 12/2014
1	Total Parenteral Nutrition 12/2014
1	Catheters 12/2014
1	Highly Active Antiretroviral Therapy (HAART) 12/2013